All News

For patients with confirmed invasive pneumococal disease, researchers compare the effects of serotype 4 with additional strains.

A study found that patients who sustained high adherence to glucose-lowering medication had a lower rate of major cardiovascular events over 10 years.

New analysis finds Black, Hispanic, unmarried, and Medicaid-enrolled women bore the heaviest burden of pandemic-related stressors during pregnancy.

Among COVID-19 vaccine recipients, researchers assess the safety and efficacy of the 2023-24 protein-based and mRNA COVID-19 vaccines.

Heidi Overton, MD, PhD, was nominated to the position amid debates on abortion pill access, childhood immunization schedules, and more.

Rick Couldry, MS/HSPA, discusses how cloud-native software resolves fragmented systems, improves tracking, and streamlines clinical workflows.

Data show semaglutide's weight loss in patients without diabetes but show how its gastrointestinal tolerability and efficacy compare with other GLP-1s.

Pharmacists navigate ACIP changes, legal battles, and shifting vaccine schedules reshaping US immunization policy and respiratory season planning.

Hailey Choi, PharmD, BCAC, CDCES, Jana Murry, PharmD, RPh, and Spencer Casella, PharmD, RPh, answer key questions on GLP-1 compounding.

Pharmacists detail a simple, tech-driven revenue cycle management workflow that empowers pharmacies to bill, reconcile, and get paid for clinical services.

New data show illness perception and functional capacity influence each other in older adults with COPD and diabetes after hospital discharge.

In part 2, Rick Couldry, MS/HSPA, provides necessary nuance to the value driving cloud-based medication management to the forefront of health care.

Data show that TyG-WC, an index combining insulin resistance and central adiposity, is the only surrogate marker independently linked to osteoporosis.

Across 3 survey periods spanning 2017 to 2023, researchers assess various institutions’ knowledge of pneumococcal vaccination.

A cohort of Black and white Americans was asked about medical racism, misinformation, COVID-19 vaccine safety, and more.

Policy shifts in Medicare and advancements in automation are creating a massive opportunity for both revenue growth and clinical impact.

This episode provides a detailed breakdown of the CVS Caremark-FTC settlement from July, exploring a shifting landscape of pharmacy benefit management.

A year of ACIP turnover, schedule changes, and lawsuits has fractured US vaccine guidance—and tied pharmacists' scope and billing to a moving target.

The current crisis of staffing shortage is not just a labor shortage but a structural failure in how pharmacies recruit and value their technician workforce.

Rick Couldry, MS/HSPA, provides his expertise for why medication management requires modernization to further streamline patient outcomes.

The expanded approval adds a self-administered autoinjector option and new label language tying LDL-C lowering to reduced cardiovascular risk.

Although DSCSA is often viewed as a regulatory burden, pharmacy leaders illustrate its necessity through harrowing case studies of supply chain failures.

Pharmacy leaders urge regional alliances, scalable clinical services, and data exchange to make pharmacist care reimbursable and routine.

Researchers assess the effects of pharmacist support in enhancing GLP-1 access in a primary care setting.

Rural pharmacist explains how local pharmacies close care gaps in older, rural patients by improving vaccine access, education, and on-time immunizations.

Pharmacists must navigate peptide and GLP-1 compounding legally by understanding 503A vs 503B rules.

The year 2026 has brought a stark paradox to American pharmacy practice, and it’s affecting the most sought-after prescription drugs on the market.

The pharmacy benefits industry is undergoing a massive restructuring, driven by a wave of government action designed to shift focus back to the patient.